SESEN BIO INC (SESN) Stock Analyst Earnings Estimates
NASDAQ:SESN - Nasdaq - US8177631053 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 11.24M | 26.544M 136.16% | -100.00% | ||||||||||
| EBITDA YoY % growth | -108.27M -215.75% | -20.96M 80.64% | 28.764M 237.23% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -108.49M -214.46% | -21.08M 80.57% | 28.679M 236.05% | -80.807M -381.77% | -16.626M 79.43% | -6.63M 60.12% | -7.14M -7.69% | -7.752M -8.57% | -8.058M -3.95% | -8.16M -1.27% | -8.16M | -8.262M -1.25% | |
| Operating Margin | N/A | -187.54% | 108.04% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -1.20 -122.22% | -0.23 80.83% | -0.10 56.52% | -0.41 -1,900.00% | -0.09 95.41% | -0.03 66.67% | -0.02 33.33% | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -0.80 -2,100.00% | -2.24 | 1.44 | 64.35% |
| Q3 2022 Q2Q % growth | 2.00 455.56% | -1.63 | 3.63 | 222.55% |
| Q2 2022 Q2Q % growth | -3.20 -2,033.33% | -2.65 | -0.55 | -20.66% |
| Q1 2022 Q2Q % growth | 0.00 100.00% | -0.10 | 0.10 | 100.00% |
| Q4 2021 Q2Q % growth | 0.04 136.36% | -0.07 | 0.11 | 153.48% |
| Q3 2021 Q2Q % growth | 0.36 289.47% | -0.07 | 0.43 | 604.20% |
| Q2 2021 Q2Q % growth | -0.15 37.50% | -0.06 | -0.09 | -132.21% |
| Q1 2021 Q2Q % growth | -0.35 -212.90% | -0.08 | -0.27 | -347.55% |
| Q4 2020 Q2Q % growth | -0.11 65.63% | -0.11 | 0.00 | -1.10% |
| Q3 2020 Q2Q % growth | -0.19 -46.15% | -0.08 | -0.11 | -132.84% |
| Q2 2020 Q2Q % growth | -0.24 64.18% | -0.10 | -0.14 | -152.11% |
| Q1 2020 Q2Q % growth | 0.31 487.50% | -0.09 | 0.40 | 450.67% |
| Q4 2019 Q2Q % growth | -0.32 | -0.08 | -0.24 | -276.49% |
| Q3 2019 Q2Q % growth | -0.13 | -0.12 | -0.01 | -10.83% |
| Q2 2019 Q2Q % growth | -0.67 | -0.11 | -0.56 | -511.04% |
| Q1 2019 Q2Q % growth | -0.08 | -0.09 | 0.01 | 10.36% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | 543.997K | -543.997K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1900% | -1900% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |